10-Q · 2026-11-09
AbCellera Biologics Inc. reports its Q3 results, highlighting key developments in the pharmaceutical preparations industry and potential impacts on future growth.
| Name | AbCellera Biologics Inc. |
|---|---|
| CIK | 0001703057 |
| Tickers | ABCL |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | A1 British Columbia, Canada |
| Phone | (604) 559-9005 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
AbCellera Biologics Inc. reports its Q3 results, highlighting key developments in the pharmaceutical preparations industry and potential impacts on future growth.
AbCellera Biologics announces Q3 2026 results, highlighting significant clinical advancements and financial performance in the pharmaceutical preparations sector.
329 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | 4 | FORM 4 | 0001834411-26-000013 | 9612 | ||||||
| 2026-11-13 | 4 | FORM 4 | 0001834449-26-000011 | 5142 | ||||||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-460670 | 005-91923 | 261552686 | 34 | 8885 | |||
| 2026-11-13 | 4 | FORM 4 | 0001834411-26-000010 | 5508 | ||||||
| 2026-11-12 | 4 | FORM 4 | 0001834449-26-000009 | 5457 | ||||||
| 2026-11-09 | 10-Q | 10-Q | 0001703057-26-000059 | 001-39781 | 261536530 | 34 | 6752959 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001703057-26-000058 | 001-39781 | 261536292 | 34 | 3339790 | 1 | 1 |
| 2026-08-24 | 4 | FORM 4 | 0001628280-26-058684 | 6532 | ||||||
| 2026-08-18 | 4 | FORM 4 | 0001834423-26-000008 | 5454 | ||||||
| 2026-08-14 | 4 | FORM 4 | 0001834411-26-000008 | 5509 | ||||||
| 2026-08-14 | 4 | FORM 4 | 0001628280-26-057007 | 6532 | ||||||
| 2026-08-13 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-26-349353 | 001-39781 | 261274141 | 34 | 616519 | 1 | 1 |
| 2026-08-13 | 424B5 | 424B5 | 0001193125-26-349333 | 333-285367 | 261274095 | 33 | 785844 | 1 | 1 | |
| 2026-08-13 | 4 | FORM 4 | 0001628280-26-056653 | 6210 | ||||||
| 2026-08-11 | 424B5 | 424B5 | 0001193125-26-344944 | 333-285367 | 261264202 | 33 | 641184 | |||
| 2026-08-10 | 8-K | 8-K | 7.01,9.01 | 0001703057-26-000053 | 001-39781 | 261256254 | 34 | 3888205 | 1 | 1 |
| 2026-08-07 | 8-K | 8-K | 8.01,9.01 | 0001703057-26-000049 | 001-39781 | 261255024 | 34 | 427380 | 1 | 1 |
| 2026-08-05 | 10-Q | 10-Q | 0001703057-26-000046 | 001-39781 | 261244074 | 34 | 5635131 | 1 | 1 | |
| 2026-08-05 | 8-K | 8-K | 2.02,7.01,9.01 | 0001703057-26-000044 | 001-39781 | 261243844 | 34 | 1676758 | 1 | 1 |
| 2026-07-29 | 8-K | 8-K | 8.01,9.01 | 0001703057-26-000039 | 001-39781 | 261215507 | 34 | 746807 | 1 | 1 |
| 2026-07-06 | 4 | FORM 4 | 0001628280-26-047400 | 5687 | ||||||
| 2026-07-06 | 3 | FORM 3 | 0001628280-26-047399 | 3216 | ||||||
| 2026-07-06 | 4 | FORM 4 | 0001628280-26-047396 | 5706 | ||||||
| 2026-07-06 | 8-K | 8-K | 5.02,9.01 | 0001703057-26-000037 | 001-39781 | 261155500 | 34 | 498844 | 1 | 1 |
| 2026-06-17 | 8-K | 8-K | 8.01,9.01 | 0001703057-26-000035 | 001-39781 | 261097323 | 34 | 690723 | 1 | 1 |
| 2026-06-12 | 4 | FORM 4 | 0001628280-26-042739 | 5697 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001685889-26-000002 | 5687 | ||||||
| 2026-06-12 | 4 | FORM 4 | 0001834423-26-000006 | 5683 | ||||||
| 2026-06-12 | 8-K | 8-K | 5.07 | 0001703057-26-000033 | 001-39781 | 261085626 | 34 | 142551 | 1 | 1 |
| 2026-06-11 | 3 | FORM 3 | 0001628280-26-042450 | 498096 | ||||||
| 2026-06-05 | 8-K | 8-K | 5.02,9.01 | 0001703057-26-000031 | 001-39781 | 261067701 | 34 | 451142 | 1 | 1 |
| 2026-06-03 | 4 | FORM 4 | 0001834411-26-000006 | 7940 | ||||||
| 2026-05-18 | 4 | FORM 4 | 0001834423-26-000004 | 5452 | ||||||
| 2026-05-11 | 10-Q | 10-Q | 0001703057-26-000028 | 001-39781 | 26963481 | 34 | 5066719 | 1 | 1 | |
| 2026-05-11 | 8-K | 8-K | 2.02,7.01,9.01 | 0001703057-26-000027 | 001-39781 | 26963316 | 34 | 3162949 | 1 | 1 |
| 2026-05-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-057139 | 005-91923 | 26953326 | 34 | 14482 | |||
| 2026-04-29 | ARS | ARS | 0001703057-26-000023 | 001-39781 | 26914775 | 34 | 28413382 | |||
| 2026-04-29 | DEFA14A | DEFA14A | 0001703057-26-000021 | 001-39781 | 26913929 | 34 | 338693 | |||
| 2026-04-29 | DEF 14A | DEF 14A | 0001703057-26-000020 | 001-39781 | 26913890 | 34 | 2976685 | 1 | 1 | |
| 2026-03-02 | 4 | FORM 4 | 0001834449-26-000004 | 5241 | ||||||
| 2026-02-27 | 4 | FORM 4 | 0001834449-26-000002 | 5242 | ||||||
| 2026-02-27 | 4 | FORM 4 | 0001834411-26-000004 | 5295 | ||||||
| 2026-02-24 | S-8 | S-8 | 0001703057-26-000013 | 333-293694 | 26672508 | 33 | 820639 | 1 | 1 | |
| 2026-02-24 | 10-K | 10-K | 0001703057-26-000012 | 001-39781 | 26672345 | 34 | 19363816 | 1 | 1 | |
| 2026-02-24 | 8-K | 8-K | 2.02,7.01,9.01 | 0001703057-26-000010 | 001-39781 | 26671759 | 34 | 1931180 | 1 | 1 |
| 2026-01-14 | 8-K | 8-K | 7.01,9.01 | 0001703057-26-000003 | 001-39781 | 26533915 | 34 | 4495495 | 1 | 1 |
| 2026-01-05 | 4 | FORM 4 | 0001834411-26-000002 | 5564 | ||||||
| 2026-01-05 | 4 | FORM 4 | 0001834412-26-000002 | 5577 | ||||||
| 2026-01-05 | 4 | FORM 4 | 0001834424-26-000002 | 5542 | ||||||
| 2026-01-05 | 4 | FORM 4 | 0001834418-26-000002 | 5575 | ||||||
| 2025-12-19 | 4 | FORM 4 | 0001685889-25-000008 | 5519 | ||||||
| 2025-12-19 | 3 | FORM 3 | 0001685889-25-000006 | 5631 | ||||||
| 2025-12-19 | 4 | FORM 4 | 0001834449-25-000004 | 4930 | ||||||
| 2025-12-18 | 8-K | 8-K | 7.01,9.01 | 0001703057-25-000034 | 001-39781 | 251582735 | 34 | 511146 | 1 | 1 |
| 2025-11-28 | 8-K | 8-K | 4.01,9.01 | 0001703057-25-000032 | 001-39781 | 251534975 | 34 | 291942 | 1 | 1 |
| 2025-11-26 | 4 | FORM 4 | 0001834423-25-000004 | 5243 | ||||||
| 2025-11-12 | 8-K | 8-K | 5.02,9.01 | 0001703057-25-000029 | 001-39781 | 251471469 | 34 | 532532 | 1 | 1 |
| 2025-11-06 | 10-Q | 10-Q | 0001703057-25-000025 | 001-39781 | 251458853 | 34 | 6040833 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0001703057-25-000024 | 001-39781 | 251458662 | 34 | 1406358 | 1 | 1 |
| 2025-09-10 | 8-K | 8-K | 8.01,9.01 | 0001703057-25-000018 | 001-39781 | 251305231 | 34 | 472051 | 1 | 1 |
| 2025-08-07 | 10-Q | 10-Q | 0001703057-25-000011 | 001-39781 | 251194801 | 34 | 5970402 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-25-038927 | 001-39781 | 251194592 | 34 | 1732798 | 1 | 1 |
| 2025-07-01 | 4 | FORM 4 | 0001628280-25-033735 | 5484 | ||||||
| 2025-06-16 | 4 | FORM 4 | 0001628280-25-031647 | 5471 | ||||||
| 2025-06-16 | 4 | FORM 4 | 0001628280-25-031646 | 5464 | ||||||
| 2025-06-13 | 8-K | 8-K | 5.07 | 0001628280-25-031219 | 001-39781 | 251045582 | 34 | 142553 | 1 | 1 |
| 2025-05-30 | 8-K | 8-K | 8.01,9.01 | 0001628280-25-028529 | 001-39781 | 251009558 | 34 | 695942 | 1 | 1 |
| 2025-05-14 | 8-K | 8-K | 8.01,9.01 | 0001628280-25-025573 | 001-39781 | 25947073 | 34 | 753008 | 1 | 1 |
| 2025-05-13 | 8-K | 8-K | 8.01,9.01 | 0001628280-25-025006 | 001-39781 | 25939180 | 34 | 754913 | 1 | 1 |
| 2025-05-08 | 10-Q | 10-Q | 0001628280-25-023836 | 001-39781 | 25926563 | 34 | 5901262 | 1 | 1 | |
| 2025-05-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-25-023808 | 001-39781 | 25926276 | 34 | 2662800 | 1 | 1 |
| 2025-04-29 | ARS | ARS | 0001628280-25-020746 | 001-39781 | 25888714 | 34 | 24624316 | |||
| 2025-04-29 | DEFA14A | DEFA14A | 0001628280-25-020729 | 001-39781 | 25888430 | 34 | 338996 | |||
| 2025-04-29 | DEF 14A | DEF 14A | 0001628280-25-020703 | 001-39781 | 25888127 | 34 | 2391598 | 1 | 1 | |
| 2025-03-11 | 4 | FORM 4 | 0001628280-25-012154 | 5249 | ||||||
| 2025-03-10 | 4 | FORM 4 | 0001628280-25-011750 | 5247 | ||||||
| 2025-03-07 | 4 | FORM 4 | 0001628280-25-011254 | 5249 | ||||||
| 2025-02-27 | S-3ASR | S-3ASR | 0001193125-25-039391 | 333-285367 | 25680621 | 33 | 1343748 | 1 | 1 | |
| 2025-02-27 | S-8 | S-8 | 0001628280-25-008708 | 333-285351 | 25679849 | 33 | 848346 | 1 | 1 | |
| 2025-02-27 | 10-K | 10-K | 0001628280-25-008689 | 001-39781 | 25679324 | 34 | 17364089 | 1 | 1 | |
| 2025-02-27 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-25-008650 | 001-39781 | 25678854 | 34 | 2507847 | 1 | 1 |
| 2025-02-18 | 8-K | 8-K | 8.01 | 0001628280-25-005983 | 001-39781 | 25633588 | 34 | 175667 | 1 | 1 |
| 2025-01-03 | 4 | FORM 4 | 0001628280-25-000237 | 5553 | ||||||
| 2025-01-03 | 4 | FORM 4 | 0001628280-25-000235 | 5585 | ||||||
| 2025-01-03 | 4 | FORM 4 | 0001628280-25-000233 | 5577 | ||||||
| 2025-01-03 | 4 | FORM 4 | 0001628280-25-000232 | 5587 | ||||||
| 2024-12-05 | 4 | FORM 4 | 0001628280-24-050097 | 4941 | ||||||
| 2024-11-26 | 4 | FORM 4 | 0001628280-24-049327 | 7945 | ||||||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-118908 | 005-91923 | 241462284 | 34 | 89179 | |||
| 2024-11-04 | 10-Q | 10-Q | 0001628280-24-045026 | 001-39781 | 241424119 | 34 | 6193880 | 1 | 1 | |
| 2024-11-04 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-24-045022 | 001-39781 | 241424001 | 34 | 1359260 | 1 | 1 |
| 2024-10-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001088875-24-000098 | 005-91923 | 241361735 | 34 | 7043 | |||
| 2024-09-24 | 4 | FORM 4 | 0001628280-24-041217 | 7945 | ||||||
| 2024-08-29 | 4 | FORM 4 | 0001628280-24-038829 | 5255 | ||||||
| 2024-08-06 | 10-Q | 10-Q | 0001628280-24-035248 | 001-39781 | 241180216 | 34 | 18763909 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-24-035229 | 001-39781 | 241179753 | 34 | 1938754 | 1 | 1 |
| 2024-06-24 | 4 | FORM 4 | 0001628280-24-029675 | 9898 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001628280-24-029673 | 5230 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001628280-24-029668 | 5210 | ||||||
| 2024-06-24 | 4 | FORM 4 | 0001628280-24-029666 | 5217 | ||||||
| 2024-06-13 | 8-K | 8-K | 5.07 | 0001628280-24-028097 | 001-39781 | 241041959 | 34 | 150615 | 1 | 1 |
| 2024-06-03 | 4 | FORM 4 | 0001628280-24-026338 | 7945 | ||||||
| 2024-05-07 | 10-Q | 10-Q | 0001628280-24-021159 | 001-39781 | 24922822 | 34 | 5671080 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0001628280-24-021115 | 001-39781 | 24922329 | 34 | 1924010 | 1 | 1 |
| 2024-04-29 | ARS | ARS | 0001628280-24-019043 | 001-39781 | 24892001 | 34 | 24254056 | |||
| 2024-04-29 | DEFA14A | DEFA14A | 0001628280-24-019035 | 001-39781 | 24891858 | 34 | 336528 | |||
| 2024-04-29 | DEF 14A | DEF 14A | 0001628280-24-019019 | 001-39781 | 24891419 | 34 | 2017785 | 1 | 1 | |
| 2024-02-27 | 4 | FORM 4 | 0001703057-24-000026 | 7944 | ||||||
| 2024-02-23 | 8-K | 8-K | 5.02,9.01 | 0001703057-24-000024 | 001-39781 | 24672214 | 34 | 696581 | 1 | 1 |
| 2024-02-20 | S-8 | S-8 | 0001703057-24-000021 | 333-277192 | 24654363 | 33 | 903465 | |||
| 2024-02-20 | 10-K | 10-K | 0001703057-24-000019 | 001-39781 | 24654148 | 34 | 34514838 | 1 | 1 | |
| 2024-02-20 | 8-K | 8-K | 2.02,7.01,9.01 | 0001703057-24-000017 | 001-39781 | 24653859 | 34 | 3020952 | 1 | 1 |
| 2024-02-14 | SC 13G | SC 13G | 0001104659-24-023719 | 005-91923 | 24638777 | 34 | 91111 | |||
| 2024-02-13 | SC 13G/A | SC 13G/A | 0001193125-24-033914 | 005-91923 | 24627796 | 34 | 66180 | |||
| 2024-01-29 | SC 13G/A | AbcelleraBiologics29122023.txt | 0001088875-24-000043 | 005-91923 | 24571781 | 34 | 11204 | |||
| 2024-01-16 | 4 | FORM 4 | 0001703057-24-000008 | 5586 | ||||||
| 2024-01-16 | 4 | FORM 4 | 0001703057-24-000006 | 5554 | ||||||
| 2024-01-16 | 4 | FORM 4 | 0001703057-24-000004 | 5576 | ||||||
| 2024-01-16 | 4 | FORM 4 | 0001703057-24-000002 | 5588 | ||||||
| 2023-12-19 | 4 | FORM 4 | 0001703057-23-000049 | 4942 | ||||||
| 2023-11-28 | 8-K | 8-K | 8.01 | 0001703057-23-000047 | 001-39781 | 231447676 | 34 | 143957 | 1 | 1 |
| 2023-11-27 | 4 | FORM 4 | 0001703057-23-000044 | 7863 | ||||||
| 2023-11-08 | 4 | FORM 4 | 0001703057-23-000042 | 7159 | ||||||
| 2023-11-02 | 10-Q | 10-Q | 0001703057-23-000040 | 001-39781 | 231372825 | 34 | 26506059 | 1 | 1 | |
| 2023-11-02 | 8-K | 8-K | 2.02,7.01,9.01 | 0001703057-23-000038 | 001-39781 | 231372450 | 34 | 3793145 | 1 | 1 |
| 2023-10-13 | 8-K | 8-K | 8.01 | 0001703057-23-000034 | 001-39781 | 231323659 | 34 | 141894 | 1 | 1 |
| 2023-09-26 | 4 | FORM 4 | 0001703057-23-000032 | 6245 | ||||||
| 2023-09-14 | 4 | FORM 4 | 0001703057-23-000030 | 7387 | ||||||
| 2023-08-25 | 4 | FORM 4 | 0001703057-23-000027 | 7863 | ||||||
| 2023-08-09 | 4 | FORM 4 | 0001703057-23-000024 | 6245 | ||||||
| 2023-08-03 | 10-Q | 10-Q | 0001703057-23-000022 | 001-39781 | 231140658 | 34 | 23953981 | 1 | 1 | |
| 2023-08-03 | 8-K | 8-K | 2.02,7.01,9.01 | 0001703057-23-000020 | 001-39781 | 231140227 | 34 | 1837347 | 1 | 1 |
| 2023-06-20 | 8-K | 8-K | 5.07 | 0001703057-23-000014 | 001-39781 | 231026016 | 34 | 155593 | 1 | 1 |
| 2023-05-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-032793 | 7976 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032484 | 5235 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032481 | 5161 | ||||||
| 2023-05-24 | 8-K | 8-K | 1.01,2.03,8.01,9.01 | 0001703057-23-000011 | 001-39781 | 23953508 | 34 | 1252743 | 1 | 1 |
| 2023-05-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-028214 | 9930 | ||||||
| 2023-05-04 | 10-Q | 10-Q | 0001703057-23-000008 | 001-39781 | 23889747 | 34 | 6007449 | 1 | 1 | |
| 2023-05-04 | 8-K | 8-K | 2.02,7.01,9.01 | 0001703057-23-000005 | 001-39781 | 23889494 | 34 | 4201523 | 1 | 1 |
| 2023-04-28 | DEFA14A | DEFA14A | 0001140361-23-021665 | 001-39781 | 23867716 | 34 | 2659678 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0001140361-23-021664 | 001-39781 | 23867690 | 34 | 5523880 | 1 | 1 | |
| 2023-04-28 | ARS | ARS | 0001140361-23-021660 | 001-39781 | 23867574 | 34 | 3998787 | |||
| 2023-04-24 | SC 13D/A | SC 13D/A | 0001104659-23-049066 | 005-91923 | 23840720 | 34 | 109965 | |||
| 2023-03-13 | 8-K | 8-K | 7.01 | 0001564590-23-003427 | 001-39781 | 23725139 | 34 | 166072 | 1 | 1 |
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012199 | 7944 | ||||||
| 2023-02-21 | S-8 | S-8 | 0001193125-23-043666 | 333-269896 | 23649466 | 33 | 90228 | |||
| 2023-02-21 | 10-K | 10-K | 0001564590-23-002128 | 001-39781 | 23649275 | 34 | 17848328 | 1 | 1 | |
| 2023-02-21 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-23-002126 | 001-39781 | 23649037 | 34 | 5456839 | 1 | 1 |
| 2023-02-13 | SC 13G/A | SEC SCHEDULE 13G | 0001422849-23-000014 | 005-91923 | 23617282 | 34 | 18179 | |||
| 2023-02-06 | SC 13G/A | SC 13G/A | 0001193125-23-025646 | 005-91923 | 23591123 | 34 | 68897 | |||
| 2023-01-18 | SC 13G | AbcelleraBiologics30122022.txt | 0001088875-23-000005 | 005-91923 | 23532887 | 34 | 11087 | |||
| 2022-12-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-062412 | 9462 | ||||||
| 2022-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-062090 | 5132 | ||||||
| 2022-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-059580 | 5103 | ||||||
| 2022-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-059579 | 5127 | ||||||
| 2022-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-059578 | 5111 | ||||||
| 2022-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-059573 | 5489 | ||||||
| 2022-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-059570 | 5457 | ||||||
| 2022-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-059568 | 5479 | ||||||
| 2022-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-059566 | 5489 | ||||||
| 2022-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-058300 | 7945 | ||||||
| 2022-11-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-056271 | 4811 | ||||||
| 2022-11-08 | 10-Q | 10-Q | 0001564590-22-037060 | 001-39781 | 221369610 | 34 | 8091637 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-22-037057 | 001-39781 | 221369399 | 34 | 3842670 | 1 | 1 |
| 2022-08-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-046998 | 5133 | ||||||
| 2022-08-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-046995 | 7945 | ||||||
| 2022-08-11 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001140361-22-026736,2022-08-11 | 9999999995-22-002331 | 333-256998 | 221157622 | 33 | 1685 | ||
| 2022-08-09 | 10-Q | 10-Q | 0001564590-22-028784 | 001-39781 | 221149031 | 34 | 7692287 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-22-028771 | 001-39781 | 221148732 | 34 | 4279472 | 1 | 1 |
| 2022-07-28 | UPLOAD | filename1.pdf | 0000000000-22-007912 | 39585 | ||||||
| 2022-07-22 | 10-K/A | 10-K/A | 0001564590-22-026266 | 001-39781 | 221100410 | 34 | 336224 | 1 | 1 | |
| 2022-07-22 | POS AM | POS AM | 0001140361-22-026736 | 333-256998 | 221100340 | 33 | 55464 | |||
| 2022-07-22 | CORRESP | filename1.htm | 0001140361-22-026730 | 16892 | ||||||
| 2022-07-19 | 8-K | 8-K | 5.02,9.01 | 0001564590-22-025922 | 001-39781 | 221089970 | 34 | 350356 | 1 | 1 |
| 2022-07-14 | UPLOAD | filename1.pdf | 0000000000-22-007411 | 44013 | ||||||
| 2022-07-06 | 8-K | 8-K | 5.02 | 0001564590-22-025392 | 001-39781 | 221069467 | 34 | 163662 | 1 | 1 |
| 2022-06-30 | 8-K | 8-K | 7.01,9.01 | 0001564590-22-024914 | 001-39781 | 221057345 | 34 | 199139 | 1 | 1 |
| 2022-06-21 | 8-K | 8-K | 5.07 | 0001564590-22-023707 | 001-39781 | 221027015 | 34 | 192818 | 1 | 1 |
| 2022-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-036884 | 7174 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-034983 | 5129 | ||||||
| 2022-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-030394 | 7944 | ||||||
| 2022-05-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-029542 | 7887 | ||||||
| 2022-05-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-029541 | 5129 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-029092 | 5130 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-029091 | 5207 | ||||||
| 2022-05-10 | 10-Q | 10-Q | 0001564590-22-019294 | 001-39781 | 22910071 | 34 | 6926651 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-22-019285 | 001-39781 | 22909881 | 34 | 3429073 | 1 | 1 |
| 2022-04-28 | DEFA14A | DEFA14A | 0001140361-22-016465 | 001-39781 | 22865481 | 34 | 4195577 | |||
| 2022-04-28 | DEF 14A | DEF 14A | 0001140361-22-016463 | 001-39781 | 22865471 | 34 | 2654130 | |||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016327 | 5148 | ||||||
| 2022-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-015227 | 5148 | ||||||
| 2022-03-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-014395 | 7860 | ||||||
| 2022-02-25 | S-3ASR | S-3ASR | 0001140361-22-006833 | 333-263047 | 22681294 | 33 | 2159178 | |||
| 2022-02-25 | POS AM | POS AM | 0001140361-22-006798 | 333-256998 | 22679575 | 33 | 1247380 | |||
| 2022-02-25 | S-8 | FORM S-8 | 0001140361-22-006795 | 333-263025 | 22679501 | 33 | 863866 | |||
| 2022-02-25 | 10-K | 10-K | 0001564590-22-007077 | 001-39781 | 22678320 | 34 | 29200190 | 1 | 1 | |
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013012 | 7944 | ||||||
| 2022-02-24 | 8-K | 8-K 2021 10K | 2.02,7.01,9.01 | 0001564590-22-006755 | 001-39781 | 22672162 | 34 | 5159520 | 1 | 1 |
| 2022-02-16 | 424B3 | 424B3 | 0001564590-22-005261 | 333-256998 | 22640415 | 33 | 304202 | |||
| 2022-02-15 | 8-K | 8-K | 7.01,9.01 | 0001564590-22-005256 | 001-39781 | 22640222 | 34 | 427183 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SC 13GA | 0001140361-22-005357 | 005-91923 | 22634189 | 34 | 348930 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022541 | 005-91923 | 22630451 | 34 | 159070 | |||
| 2022-02-11 | SC 13G | SEC SCHEDULE 13G | 0001422849-22-000023 | 005-91923 | 22619680 | 34 | 18120 | |||
| 2022-02-10 | SC 13G/A | SC 13G/A | 0001193125-22-034518 | 005-91923 | 22614447 | 34 | 71433 | |||
| 2022-02-03 | 5 | FORM 5 SUBMISSION | 0001209191-22-006972 | 9796 | ||||||
| 2022-02-03 | 5 | FORM 5 SUBMISSION | 0001209191-22-006967 | 6694 | ||||||
| 2022-02-03 | 5 | FORM 5 SUBMISSION | 0001209191-22-006963 | 10196 | ||||||
| 2022-02-03 | 5 | FORM 5 SUBMISSION | 0001209191-22-006960 | 5658 | ||||||
| 2021-12-10 | 4 | FORM 4 SUBMISSION | 0001209191-21-069084 | 7437 | ||||||
| 2021-12-10 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-068976 | 5748 | ||||||
| 2021-12-10 | 4 | FORM 4 SUBMISSION | 0001209191-21-068956 | 8597 | ||||||
| 2021-12-10 | 4 | FORM 4 SUBMISSION | 0001209191-21-068955 | 9161 | ||||||
| 2021-12-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-068851 | 8929 | ||||||
| 2021-12-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-068850 | 8015 | ||||||
| 2021-12-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-068849 | 6786 | ||||||
| 2021-12-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-068847 | 6759 | ||||||
| 2021-12-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-068844 | 9899 | ||||||
| 2021-12-07 | 424B3 | 424B3 | 0001564590-21-059574 | 333-256998 | 211476007 | 33 | 79783 | |||
| 2021-12-07 | 8-K | 8-K | 5.02,9.01 | 0001564590-21-059570 | 001-39781 | 211475943 | 34 | 253700 | 1 | 1 |
| 2021-12-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-068291 | 4442 | ||||||
| 2021-12-07 | 3 | FORM 3 SUBMISSION | 0001209191-21-068290 | 2842 | ||||||
| 2021-12-07 | 424B3 | 424B3 | 0001564590-21-059459 | 333-256998 | 211474109 | 33 | 78603 | |||
| 2021-12-03 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-067941 | 10157 | ||||||
| 2021-12-03 | 8-K | 8-K | 7.01,9.01 | 0001564590-21-059298 | 001-39781 | 211469484 | 34 | 251485 | 1 | 1 |
| 2021-12-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-067491 | 9897 | ||||||
| 2021-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-066133 | 8973 | ||||||
| 2021-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-064378 | 7154 | ||||||
| 2021-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-064377 | 5183 | ||||||
| 2021-11-12 | 424B3 | 424B3 | 0001564590-21-056390 | 333-256998 | 211399023 | 33 | 3404477 | |||
| 2021-11-10 | 10-Q | 10-Q | 0001564590-21-056205 | 001-39781 | 211396835 | 34 | 9864121 | 1 | 1 | |
| 2021-11-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-21-055806 | 001-39781 | 211393084 | 34 | 5111262 | 1 | 1 |
| 2021-11-04 | 424B3 | 424B3 | 0001564590-21-054537 | 333-256998 | 211380659 | 33 | 71370 | |||
| 2021-11-04 | 8-K | 8-K | 7.01,9.01 | 0001564590-21-054498 | 001-39781 | 211380215 | 34 | 197450 | 1 | 1 |
| 2021-09-24 | 4 | FORM 4 SUBMISSION | 0001209191-21-057522 | 2947 | ||||||
| 2021-09-23 | 424B3 | 424B3 | 0001564590-21-048633 | 333-256998 | 211270500 | 33 | 74076 | |||
| 2021-09-23 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-048621 | 001-39781 | 211270403 | 34 | 201890 | 1 | 1 |
| 2021-09-15 | 424B3 | 424B3 | 0001564590-21-048051 | 333-256998 | 211255931 | 33 | 64810 | |||
| 2021-09-15 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-048042 | 001-39781 | 211255684 | 34 | 193400 | 1 | 1 |
| 2021-09-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-056163 | 8656 | ||||||
| 2021-09-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-054749 | 7059 | ||||||
| 2021-09-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-054543 | 8986 | ||||||
| 2021-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-051985 | 5149 | ||||||
| 2021-08-17 | 424B3 | 424B3 | 0001564590-21-044931 | 333-256998 | 211183572 | 33 | 3037844 | |||
| 2021-08-13 | 10-Q | 10-Q | 0001564590-21-044327 | 001-39781 | 211172663 | 34 | 8282814 | 1 | 1 | |
| 2021-08-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-21-044061 | 001-39781 | 211168797 | 34 | 4917111 | ||
| 2021-07-15 | 424B3 | 424B3 | 0001564590-21-036745 | 333-256998 | 211092991 | 33 | 73470 | |||
| 2021-07-13 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-036460 | 001-39781 | 211088168 | 34 | 111951 | ||
| 2021-06-25 | 424B3 | 424B3 NO.1 | 0001564590-21-034607 | 333-256998 | 211048355 | 33 | 74785 | |||
| 2021-06-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-025366 | 5998 | ||||||
| 2021-06-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-025357 | 8887 | ||||||
| 2021-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-21-042496 | 18205 | ||||||
| 2021-06-22 | 424B3 | 424B3 | 0001193125-21-196310 | 333-256998 | 211035940 | 33 | 563706 | |||
| 2021-06-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-06-21 16:00:00 | 9999999995-21-002431 | 333-256998 | 211032945 | 33 | 1672 | ||
| 2021-06-21 | 8-K | 8-K | 5.07 | 0001564590-21-033639 | 001-39781 | 211031157 | 34 | 67810 | ||
| 2021-06-17 | CORRESP | filename1.htm | 0001193125-21-193163 | 8091 | ||||||
| 2021-06-16 | 4 | FORM 4 SUBMISSION | 0000899243-21-024295 | 10357 | ||||||
| 2021-06-16 | UPLOAD | filename1.pdf | 0000000000-21-007466 | 40115 | ||||||
| 2021-06-10 | S-1 | S-1 | 0001193125-21-187930 | 333-256998 | 211008982 | 33 | 682702 | |||
| 2021-06-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-022994 | 5039 | ||||||
| 2021-06-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-022993 | 7389 | ||||||
| 2021-06-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-022990 | 8384 | ||||||
| 2021-06-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-022989 | 6192 | ||||||
| 2021-06-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-022987 | 4810 | ||||||
| 2021-06-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-022988 | 5493 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-21-022899 | 12526 | ||||||
| 2021-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-21-022894 | 12006 | ||||||
| 2021-05-17 | 8-K/A | 8-K/A | 2.02,7.01,9.01 | 0001564590-21-028375 | 001-39781 | 21930392 | 34 | 7414683 | ||
| 2021-05-14 | 10-Q | 10-Q | 0001564590-21-028008 | 001-39781 | 21924546 | 34 | 6388220 | 1 | 1 | |
| 2021-05-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-21-027597 | 001-39781 | 21920113 | 34 | 7404964 | ||
| 2021-04-28 | DEFA14A | DEFA14A | 0001140361-21-014741 | 001-39781 | 21864137 | 34 | 891476 | |||
| 2021-04-28 | DEF 14A | DEF 14A | 0001140361-21-014738 | 001-39781 | 21864084 | 34 | 2040630 | |||
| 2021-04-23 | 4 | FORM 4 SUBMISSION | 0000899243-21-016935 | 7117 | ||||||
| 2021-04-01 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-103256 | 001-39781 | 21796048 | 34 | 26908 | ||
| 2021-03-30 | 10-K | 10-K | 0001564590-21-016713 | 001-39781 | 21787617 | 34 | 12141783 | |||
| 2021-03-29 | 8-K | 8-K | 2.02,7.01,9.01 | 0001564590-21-016135 | 001-39781 | 21782003 | 34 | 10601274 | ||
| 2021-03-02 | 8-K | 8-K | 8.01 | 0001193125-21-064713 | 001-39781 | 21701438 | 34 | 21353 | ||
| 2021-02-16 | SC 13G | SC 13G | 0001193125-21-044913 | 005-91923 | 21638793 | 34 | 72500 | |||
| 2021-02-16 | SC 13G/A | AMENDMENT NO. 2 | 0001387131-21-002342 | 005-91923 | 21631284 | 34 | 238883 | |||
| 2021-02-09 | SC 13G | SC 13G | 0001104659-21-016301 | 005-91923 | 21603864 | 34 | 225378 | |||
| 2021-02-05 | 3 | FORM 3 SUBMISSION | 0000899243-21-005107 | 13678 | ||||||
| 2020-12-28 | SC 13D | ABCELLERA BIOLOGICS INC. SCHEDULE 13D | 0001068238-20-000249 | 005-91923 | 201418873 | 34 | 382776 | |||
| 2020-12-28 | SC 13G/A | AMENDMENT TO FORM SC 13G | 0001387131-20-011672 | 005-91923 | 201414190 | 34 | 172247 | |||
| 2020-12-21 | SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-20-011461 | 005-91923 | 201405215 | 34 | 171269 | |||
| 2020-12-17 | 4 | FORM 4 SUBMISSION | 0001209191-20-064259 | 24671 | ||||||
| 2020-12-17 | 3/A | FORM 3/A SUBMISSION | 0001209191-20-064258 | 17972 | ||||||
| 2020-12-17 | 4 | FORM 4 SUBMISSION | 0000899243-20-034355 | 44658 | ||||||
| 2020-12-17 | 4 | FORM 4 SUBMISSION | 0000899243-20-034349 | 18099 | ||||||
| 2020-12-17 | 4 | FORM 4 SUBMISSION | 0000899243-20-034341 | 9709 | ||||||
| 2020-12-17 | 4 | FORM 4 SUBMISSION | 0000899243-20-034342 | 14514 | ||||||
| 2020-12-17 | 4 | FORM 4 SUBMISSION | 0000899243-20-034340 | 20195 | ||||||
| 2020-12-17 | 4 | FORM 4 SUBMISSION | 0000899243-20-034339 | 12322 | ||||||
| 2020-12-15 | S-8 | S-8 | 0001193125-20-317281 | 333-251341 | 201387880 | 33 | 133756 | |||
| 2020-12-14 | 424B4 | 424B4 | 0001193125-20-316986 | 333-250838 | 201386483 | 33 | 6694680 | |||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0001209191-20-063107 | 16014 | ||||||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0000899243-20-033648 | 20958 | ||||||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0000899243-20-033647 | 14362 | ||||||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0000899243-20-033646 | 14324 | ||||||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0000899243-20-033645 | 12330 | ||||||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0000899243-20-033644 | 13246 | ||||||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0000899243-20-033643 | 9393 | ||||||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0000899243-20-033642 | 13285 | ||||||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0000899243-20-033641 | 15818 | ||||||
| 2020-12-11 | 3 | FORM 3 SUBMISSION | 0000899243-20-033640 | 3793 | ||||||
| 2020-12-11 | CERT | 8A_Cert_ABCL.pdf | 0001354457-20-000780 | 001-39781 | 201382516 | 34 | 223401 | |||
| 2020-12-10 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-12-10 16:00:00 | 9999999995-20-003483 | 333-250838 | 201382142 | 33 | 1672 | ||
| 2020-12-10 | S-1MEF | S-1MEF | 0001193125-20-315173 | 333-251280 | 201382054 | 33 | 64088 | |||
| 2020-12-10 | SEC STAFF LETTER | filename1.pdf | 9999999997-20-005704 | 396713 | ||||||
| 2020-12-10 | S-1/A | AMENDMENT NO. 3 TO FORM S-1 | 0001193125-20-314458 | 333-250838 | 201379566 | 33 | 6816837 | |||
| 2020-12-08 | 8-A12B | 8-A12B | 0001193125-20-312822 | 001-39781 | 201375847 | 34 | 14276 | |||
| 2020-12-08 | CORRESP | filename1.htm | 0001193125-20-312816 | 11652 | ||||||
| 2020-12-08 | CORRESP | filename1.htm | 0001193125-20-312808 | 8931 | ||||||
| 2020-12-07 | S-1/A | AMENDMENT NO. 2 TO FORM S-1 | 0001193125-20-311091 | 333-250838 | 201371255 | 33 | 9621414 | |||
| 2020-12-03 | CORRESP | filename1.htm | 0001193125-20-308858 | 42230 | ||||||
| 2020-12-02 | UPLOAD | filename1.pdf | 0000000000-20-011523 | 48595 | ||||||
| 2020-11-30 | CORRESP | filename1.htm | 0001193125-20-304879 | 84489 | ||||||
| 2020-11-25 | S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001193125-20-302988 | 333-250838 | 201346803 | 33 | 6754980 | |||
| 2020-11-20 | CORRESP | filename1.htm | 0001193125-20-299512 | 39962 | ||||||
| 2020-11-20 | S-1 | S-1 | 0001193125-20-299507 | 333-250838 | 201333182 | 33 | 8515441 | |||
| 2020-11-20 | UPLOAD | filename1.pdf | 0000000000-20-011124 | 51149 | ||||||
| 2020-11-12 | SEC STAFF LETTER | filename1.pdf | 9999999997-20-005346 | 398375 | ||||||
| 2020-11-06 | DRSLTR | filename1.htm | 0000950123-20-011018 | 65143 | ||||||
| 2020-11-06 | DRS/A | filename1.htm | 0000950123-20-011017 | 377-03630 | 201295334 | 33 | 8631145 | |||
| 2020-11-02 | UPLOAD | filename1.pdf | 0000000000-20-010344 | 62070 | ||||||
| 2020-10-05 | DRS | filename1.htm | 0000950123-20-010081 | 377-03630 | 201222151 | 33 | 4994436 | |||
| 2020-05-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-20-011193 | 021-367729 | 20913744 | 33 | 9037 | ||
| 2018-08-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-18-000363 | 021-318995 | 181008664 | 33 | 7556 | ||
| 2018-03-19 | D | xslFormDX01/primary_doc.xml | 06b | 0001140361-18-014018 | 021-308029 | 18698569 | 33 | 6908 | ||
| 2017-04-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001140361-17-015051 | 021-284172 | 17744104 | 33 | 6992 |
One latest value per concept from companyfacts (262 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 326.62M | 2026-11-04 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 789.23M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 2.94M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001703057-26-000020 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.68M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001703057-26-000020 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 119.92 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001703057-26-000020 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 7.27M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001703057-26-000020 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 6.29M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001703057-26-000020 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 8.5 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001703057-26-000020 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 27,620 | 2026-08-13 | 424B5 | 2026-08-13 | 0001193125-26-349333 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 200.00M | 2026-08-13 | 424B5 | 2026-08-13 | 0001193125-26-349333 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 27,620 | 2026-08-13 | 424B5 | 2026-08-13 | 0001193125-26-349333 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 200.00M | 2026-08-13 | 424B5 | 2026-08-13 | 0001193125-26-349333 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-13 | 424B5 | 2026-08-13 | 0001193125-26-349333 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-13 | 424B5 | 2026-08-13 | 0001193125-26-349333 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 13.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilities | Accounts Payable and Other Accrued Liabilities | USD | 35.71M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001703057-23-000040 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 35.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 2.80M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0001564590-21-044327 | |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 15.04M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001703057-23-000022 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 | |
| us-gaap | AccruedRoyaltiesCurrent | Accrued Royalties, Current | USD | 3.09M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001703057-24-000019 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 27.03M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001703057-23-000040 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -3.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 238.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 11.67M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 35.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables | Allowance for Doubtful Accounts, Premiums and Other Receivables | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 | |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 2.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 76.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | Assets | Assets | USD | 1.50B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 876.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | AssetsNoncurrent | Assets, Noncurrent | USD | 623.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 600.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | BusinessCombinationContingentConsiderationLiability | Business Combination, Contingent Consideration, Liability | USD | 22.60M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityCurrent | Business Combination, Contingent Consideration, Liability, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityNoncurrent | Business Combination, Contingent Consideration, Liability, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 33.30M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 |
| us-gaap | Cash | Cash | USD | 99.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 163.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 764.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 188.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 190.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 35.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 29.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | CommonStockNoParValue | Common Stock, No Par Value | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 326.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 326.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 996.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -138.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | ConstructionInProgressGross | Construction in Progress, Gross | USD | 13.00M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0001628280-24-035248 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 83.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 35.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 48.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 16.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | -30.04M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | -201,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | -30.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent | Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent | USD | 4.30M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 | |
| us-gaap | DeferredCompensationShareBasedArrangementsLiabilityCurrent | Deferred Compensation Share-based Arrangements, Liability, Current | USD | 4.27M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | -938,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 1.96M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001703057-24-000019 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 87.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 9.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 21.24M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001703057-24-000019 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 134.83M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 27.85M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 34.06M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 2.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 4.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 1.06M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 56.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 56.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 9.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 8.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 11.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | DeferredTaxLiabilitiesOtherFiniteLivedAssets | Deferred Tax Liabilities, Other Finite-Lived Assets | USD | 2.01M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 30.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | Depreciation | Depreciation | USD | 17.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 16.05M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001703057-25-000025 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 20.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | Dividends | Dividends | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | DividendsCash | Dividends, Cash | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.45 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.45 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.175 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.27 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.069 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.066 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 18.23M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.034 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxSettlements | Effective Income Tax Rate Reconciliation, Tax Settlement, Percent | pure | 0.5 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -847,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 7.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | EquityMethodInvestmentDividendsOrDistributions | Proceeds from Equity Method Investment, Distribution | USD | 30.11M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | EquitySecuritiesFvNiCurrentAndNoncurrent | EquitySecuritiesFvNiCurrentAndNoncurrent | USD | 16.50M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001628280-24-045026 | |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueAmount | Equity Securities without Readily Determinable Fair Value, Amount | USD | 26.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | USD | 6.10M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019294 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019294 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 33.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths | Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months | USD | 3.73M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001703057-25-000025 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 4.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 10.43M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019294 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five | USD | 2.98M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001703057-25-000025 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four | USD | 3.73M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001703057-25-000025 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three | USD | 3.73M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001703057-25-000025 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two | USD | 3.73M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001703057-25-000025 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 2.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 3.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 4.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 4.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 72.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 17.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -855,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 83.23M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | Goodwill | Goodwill | USD | 47.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | GoodwillAcquiredDuringPeriod | Goodwill, Acquired During Period | USD | 16.31M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | GoodwillImpairedAccumulatedImpairmentLoss | Goodwill, Impaired, Accumulated Impairment Loss | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | GovernmentAssistanceAmount | GovernmentAssistanceAmount | USD | 118.18M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0001628280-24-021159 |
| us-gaap | GovernmentAssistanceAmountCumulative | GovernmentAssistanceAmountCumulative | USD | 24.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | GovernmentAssistanceAmountCumulativeCurrent | GovernmentAssistanceAmountCumulativeCurrent | USD | 16.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | GovernmentAssistanceAmountCumulativeNoncurrent | GovernmentAssistanceAmountCumulativeNoncurrent | USD | 7.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | GovernmentAssistanceLiability | GovernmentAssistanceLiability | USD | 188.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | GovernmentAssistanceLiabilityCurrent | GovernmentAssistanceLiabilityCurrent | USD | 8.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | GovernmentAssistanceLiabilityNoncurrent | GovernmentAssistanceLiabilityNoncurrent | USD | 180.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | 8.40M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -188.46M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -151.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 10.87M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 1.70M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 11.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | IncomeTaxesReceivableNoncurrent | Income Taxes Receivable, Noncurrent | USD | 17.40M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001703057-23-000022 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -11.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 12.32M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -54.11M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 11.86M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 252,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | IncomeTaxReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | USD | 774,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 6.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -13.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | -4.97M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001703057-26-000028 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 66.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | IncreaseDecreaseInIncomeTaxesReceivable | Increase (Decrease) in Income Taxes Receivable | USD | -19.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -3.06M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -4.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | IncreaseDecreaseInOtherOperatingCapitalNet | Increase (Decrease) in Other Operating Assets and Liabilities, Net | USD | -1.69M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | -13.10M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001703057-26-000028 |
| us-gaap | IncreaseDecreaseInRoyaltiesPayable | Increase (Decrease) in Royalties Payable | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001628280-24-045026 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfPreferredStock | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock | shares | 63.26M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 38.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 10.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | InventoryNet | Inventory, Net | USD | 7.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 3.64M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001703057-26-000028 |
| us-gaap | InvestmentInterestRate | Investment Interest Rate | pure | 0.01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures | Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | USD | 63.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 108.20M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0001628280-24-035248 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 160.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 14.24M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 14.86M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 14.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 14.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 14.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | Liabilities | Liabilities | USD | 437.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.50B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 70.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 366.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 190,000 | 2020-12-31 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056205 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 500.00M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | 800,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 214.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -197.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 19.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -139.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -139.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -139.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 423,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-14 | 0001564590-21-028008 |
| us-gaap | NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 | Noncash or Part Noncash Acquisition, Intangible Assets Acquired | USD | 9.06M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 22.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 196.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -173.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 11.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 143.22M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 5.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 128.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 130.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 5.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.06 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 68.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 63.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | USD | 813,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 10.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -5.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -2.71M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | PaymentForContingentConsiderationLiabilityFinancingActivities | Payment for Contingent Consideration Liability, Financing Activities | USD | 2.55M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 |
| us-gaap | PaymentsForProceedsFromLoansReceivable | Payments for (Proceeds from) Loans Receivable | USD | -33.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 799,000 | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-14 | 0001564590-21-028008 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001703057-24-000019 |
| us-gaap | PaymentsToAcquireEquityMethodInvestments | Payments to Acquire Equity Method Investments | USD | 7.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 5.03M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0001564590-21-044327 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 624.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 7.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 33.82M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 4.92M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0001564590-21-044327 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 2.88M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 | |
| us-gaap | ProceedsFromCollectionOfLongtermLoansToRelatedParties | Proceeds from Collection of Long-term Loans to Related Parties | USD | 1.57M | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056205 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 522.84M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 7.60M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001628280-24-045026 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 74.66M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 188.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | ProceedsFromLegalSettlements | Proceeds from Legal Settlements | USD | 36.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | ProceedsFromPaymentsForLongTermLoansForRelatedParties | Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties | USD | 1.78M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 |
| us-gaap | ProceedsFromRepaymentsOfShortTermDebt | Proceeds from (Repayments of) Short-term Debt | USD | -387,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 429.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 1.58M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-04 | 0001628280-24-045026 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -139.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 304.24M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001703057-23-000040 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 277.21M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001703057-23-000040 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 38.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 1.82M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | USD | 387,000 | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056205 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 136.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 26.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 3.12M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 1.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 25.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 200,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | RestrictedInvestmentsNoncurrent | Restricted Investments, Noncurrent | USD | 6.76M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 | |
| us-gaap | RestructuringAndRelatedCostCostIncurredToDate1 | Restructuring and Related Cost, Cost Incurred to Date | USD | 3.20M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.1 | 2023-10-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 2.00M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001628280-25-008689 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -168.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 23.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | RevenueRemainingPerformanceObligation | Revenue, Remaining Performance Obligation, Amount | USD | 56.00M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001703057-26-000046 | |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 13.60M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-25 | 0001564590-22-007077 | |
| us-gaap | SellingAndMarketingExpense | Selling and Marketing Expense | USD | 8.76M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001703057-25-000025 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 39.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 35.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | ShortTermLeaseCommitmentAmount | Short-term Lease Commitment, Amount | USD | 12.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 1.06B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.1 | 2020-12-04 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 | |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 188.82M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 942,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 10.20M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001703057-24-000019 | |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 1.21M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-14 | 0001564590-21-028008 | |
| us-gaap | UnbilledReceivablesCurrent | Unbilled Receivables, Current | USD | 62.09M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0001564590-21-044327 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 109,000 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions | USD | 109,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 109,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001564590-23-002128 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001703057-24-000019 | |
| us-gaap | VariableLeasePayment | Variable Lease, Payment | USD | 500,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001703057-26-000012 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 308.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 308.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001703057-26-000059 |